IRIS
CILIBERTO, GENNARO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.029
AS - Asia 4.938
EU - Europa 2.098
SA - Sud America 1.823
AF - Africa 108
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 19
Totale 17.036
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.719
SG - Singapore 1.853
BR - Brasile 1.474
CN - Cina 1.277
IT - Italia 816
VN - Vietnam 695
IN - India 680
SE - Svezia 418
GB - Regno Unito 380
CA - Canada 218
DE - Germania 162
AR - Argentina 136
HK - Hong Kong 82
BD - Bangladesh 72
EC - Ecuador 67
ID - Indonesia 63
MX - Messico 59
FI - Finlandia 46
ZA - Sudafrica 44
JP - Giappone 42
CO - Colombia 36
RU - Federazione Russa 36
CL - Cile 35
UA - Ucraina 34
PL - Polonia 33
IQ - Iraq 32
NL - Olanda 32
PY - Paraguay 31
ES - Italia 27
VE - Venezuela 22
MA - Marocco 20
RO - Romania 19
SA - Arabia Saudita 19
TR - Turchia 16
AU - Australia 14
PK - Pakistan 14
UZ - Uzbekistan 14
AE - Emirati Arabi Uniti 13
CZ - Repubblica Ceca 13
IR - Iran 13
EG - Egitto 12
EU - Europa 12
FR - Francia 11
KE - Kenya 11
IE - Irlanda 9
LT - Lituania 9
PE - Perù 9
UY - Uruguay 9
AT - Austria 8
GR - Grecia 7
JM - Giamaica 7
JO - Giordania 7
AL - Albania 6
AZ - Azerbaigian 6
IL - Israele 6
NZ - Nuova Zelanda 6
TT - Trinidad e Tobago 6
DZ - Algeria 5
TN - Tunisia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BB - Barbados 4
BO - Bolivia 4
CH - Svizzera 4
EE - Estonia 4
HN - Honduras 4
KZ - Kazakistan 4
BG - Bulgaria 3
BN - Brunei Darussalam 3
CY - Cipro 3
DO - Repubblica Dominicana 3
KR - Corea 3
LB - Libano 3
NO - Norvegia 3
NP - Nepal 3
XK - ???statistics.table.value.countryCode.XK??? 3
BE - Belgio 2
DK - Danimarca 2
MD - Moldavia 2
MK - Macedonia 2
MO - Macao, regione amministrativa speciale della Cina 2
MY - Malesia 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
SI - Slovenia 2
SN - Senegal 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
DM - Dominica 1
GM - Gambi 1
GN - Guinea 1
GT - Guatemala 1
Totale 17.021
Salva come PNG Salva come JPEG
Città #
Chandler 1.195
Dallas 1.044
Singapore 645
Santa Clara 589
Hefei 580
Bengaluru 578
Milan 511
Princeton 499
Lawrence 495
Chicago 327
London 301
Wilmington 295
Ho Chi Minh City 264
Ottawa 165
Ashburn 154
Des Moines 153
Hanoi 141
Beijing 139
Boardman 136
São Paulo 126
Munich 122
Hong Kong 77
Los Angeles 67
Shanghai 61
New York 49
Guangzhou 46
Council Bluffs 45
Norwalk 42
Pune 42
Rome 42
Rio de Janeiro 39
Turku 36
Catanzaro 34
The Dalles 34
Brooklyn 33
Tokyo 33
Brasília 31
San Francisco 30
Haiphong 29
Porto Alegre 27
Boston 26
Belo Horizonte 25
Columbus 25
Warsaw 25
Campinas 23
Da Nang 23
Redmond 23
Wuhan 23
Curitiba 22
Guayaquil 22
Quito 22
Redwood City 22
Biên Hòa 20
Naples 20
Atlanta 19
Johannesburg 19
Montreal 19
Asunción 18
Buenos Aires 18
Stockholm 18
Dhaka 17
Hải Dương 17
Salvador 17
Thái Bình 17
Assago 16
Ninh Bình 16
Shenzhen 16
Falls Church 15
Jakarta 14
Manaus 14
Mexico City 14
Phoenix 14
Washington 14
Chennai 13
Guarulhos 13
Santo André 13
Baghdad 12
Bắc Ninh 12
Can Tho 12
Charlotte 12
Seattle 12
Tashkent 12
Wuxi 12
Ann Arbor 11
Ha Long 11
Maceió 11
Rui'an 11
Amsterdam 10
Bauru 10
Helsinki 10
Manchester 10
Sorocaba 10
Thái Nguyên 10
Contagem 9
Jinan 9
Nairobi 9
Petrópolis 9
Raleigh 9
Ribeirão Preto 9
Toronto 9
Totale 10.179
Salva come PNG Salva come JPEG
Nome #
The 12-week kinetics of anti-SARS-CoV-2 antibodies in different haematological cancers after vaccination with BNT162b2 472
ADENOVIRAL VECTORS ENCODING ERYTHROPOIETIN AND THEIR USE IN GENE THERAPY 74
59. Structural characterization of a biologically active human Lipocortin 1 expressed in Escherichia coli 70
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study 69
A METHODOLOGY FOR SELECTING SUPERAGONISTS, ANTAGONISTS AND SUPERANTAGONISTS OF HORMONES WHOSE RECEPTOR COMPLEX INCLUDES GP 130 66
T-CELL PEPTIDE EPITOPES FROM CARCINOEMBRYONIC ANTIGEN, IMMUNOGENIC ANALOGS, AND USES THEREOF 64
A general method to select for M13 clones carrying base pair substitution mutants constructed in vitro 62
Monitoring of melanoma clinical progression by circulating NK and T cells immunoprofiling: a potential role for CCR7 in metastatic spread 62
Ferritin heavy chain is a negative regulator of ovarian cancer stem cell expansion and epithelial to mesenchymal transition. 62
ADENOVIRAL VECTORS FOR MUTANTS OF HUMAN INTERLEUKIN 6 (HIL-6) WITH HIL-6 ANTAGONIST ACTIVITY, PHARMACEUTICAL COMPOSITIONS THEREWITH AND THEIR USES 62
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 61
A novel method for site-directed mutagenesis: its application to an eukaryotic tRNAPro gene promoter 60
A bipartite activation domain is responsible for the activity of transcription factor HNF1/LFB1 in cells of hepatic and non-hepatic origin 60
Interleukin 6 deficient mice are protected from bone loss caused by estrogen depletion 60
A novel minigene scaffold for therapeutic cancer vaccines 59
A fast and sensitive colorimetric assay for IL-6 on hepatoma cells based on the production of a secreted form of alkaline phosphatase (SEAP) 57
A novel Chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines 57
A Multimeric Synthetic Combinatorial peptide library. A Multimeric Synthetic Combinatorial peptide library 57
A PARADIGM SHIFT FOR ERYTHROPOIETIN: NO LONGER A SPECIALIZED GROWTH FACTOR, BUT RATHER THAN AN ALL-PURPOSE TISSUE-PROTECTIVE AGENT 57
RHESUS EPITHELIAL CELL ADHESION MOLECULE, NUCLEIC ACID ENCODING THE SAME, AND USES THEREOF 56
A functionally orthogonal estrogen Receptor-based transcription switch Tightly controlled by a non-steroid synthetic ligand 56
The Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells 56
Mammosphere-forming cells from breast cancer cell lines as a tool for the identification of CSC-like- and early progenitor-targeting drugs 54
A novel multi-drug metronomic chemotherapy significantly delays tumor growth in mice 54
A paradigm shift for erythropoietin: no longer a specialized growth factor, but rather an all-purpose tissue-protective agent 54
A prokaryotic tRNA Tyr gene,inactive in Xenpous Laevis oocytes, is activated by recombination with an eukaryotic tRNA Pro gene 54
A fast and sensitive colorimetric assay for IL-6 in hepatoma cells based on the production of a secreted form of alkaline phsphatase (SEAP) 52
Adenovirus-mediated gene transfer of a human IL-6 antagonist 52
ANTAGONISTS OF HUMAN INTERLEUKIN-6 THAT ARE TOTALLY INCAPABLE OF BINDING GP 130, AND THEIR USE IN THE PREPARATION OF PHARMACEUTICAL COMPOUNDS 52
CHIMERIC BIOMARKER FOR THE EARLY DIAGNOSIS AND IMMUNOTHERAPY OF CANCER 52
PREPARATION OF RECOMBINANT ADENOVIRUS CARRYING A REP GENE OF ADENO-ASSOCIATED VIRUS 52
Analysis of T and Natural Killer cells immune response in Ipilimumab treated 52
A novel mouse model for evaluation and prediction of HLA-A2-restricted CEA cancer vaccine responses 50
Liver failure and defective hepatocyte regeneration in Interleukin-6 deficient mice 50
Cancer stem cells and the slow cycling phenotype: How to cut the gordian knot driving resistance to therapy in melanoma 50
Genome-wide analysis of copy number alterations led to the characterisation of PDCD10 as oncogene in ovarian cancer 50
HORMONE-DEPENDENT FORMS OF THE ADENO-ASSOCIATED VIRUS, REP PROTEINS, DNA SEQUENCES CODING FOR THEM, VECTORS CONTAINING THEM, AND REGULATORY METHODS OF THEIR INTRACELLULAR ACTIVITY 49
MUTANT INTERLEUKIN 6 WITH IMPROVED BIOLOGICAL ACTIVITY OVER WILD INTERLEUKIN 6 49
WT1 CpG islands methylation in human lung cancer: a pilot study 49
An improved helper-dependent adenoviral vector allows persistent gene expression after i.m. delivery and overcomes pre-existing immunity to adenovirus 48
A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope 48
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience 48
Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2s-M2 tetracycline transactivator and repressor system 47
MicroRNAs regulate resistance to target therapy in melanoma 47
IMMUNOTHERAPY AGAINST ERBB-3 RECEPTOR 47
Liver specific expression of cloned human genes 47
miR-579-3p controls melanoma progression and resistance to target therapy 46
ANTI-TUMOUR PHARMACEUTICAL COMPOSITIONS CAPABLE OF REDUCING DRUG RESISTANCE IN TUMOUR CELLS 46
In vivo neutralization of human IL-6 (hIL-6) achieved by immunization of hIL-6-transgenic mice with a hIL-6 receptor antagonist 46
HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome 46
Involvement of the Arg179 in the active site of human IL-6 46
A moonshot approach toward the management of cancer patients in the COVID-19 time: what have we learned and what could the Italian network of cancer centers (Alliance Against Cancer, ACC) do after the pandemic wave? 46
Regulation of C-reactive protein, haptoglobin and hemopexin gene expression 45
COVID-19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experience 45
PROGRESS AND PROSPECTS: TRANSCRIPTION REGULATORY SYSTEMS 44
Two distinct and independent sites on IL-6 trigger gp130 dimer formation and signalling 44
Inhibition of Stearoyl-Coa desaturase 1 (SCD1) enzymatic activity reverts BRAFi and MEKi-induced selection of cancer stem cells in BRAF-mutated malignant melanoma 44
CARCINOEMBRYONIC ANTIGEN FUSIONS PROTEINS AND USES THEREOF 44
INTERLEUKIN-6 (IL-6) ANTAGONISTS 44
Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas 44
RECOMBINANT VECTORS DERIVED FROM ADENO-ASSOCIATED VIRUS SUITABLE FOR GENE THERAPY 44
Telomerase Reverse Transcriptase Fusion Protein , Nucleotides Encoding it, and uses thereof 44
A federated learning system for precision oncology in Europe: DigiONE 43
Monovalent phage display of human Interleukin (hIL)-6: selection superbinder variants for a complex molecular repertoire in hIL-6 D-Helix 43
RHESUS HER2/NEU, NUCLEOTIDES ENCODING SAME, AND USES THEREOF 43
Vorinostat synergizes with EGFR inhibitors in NSCLC cells by increasing ROS via up-regulation of the major mitochondrial porin VDAC1 and modulation of the c-Myc-NRF2-KEAP1 pathway. 43
Low glycemic index diet, exercise and vitamin D to reduce breast cancer recurrence (DEDiCa): design of a clinical trial 43
Pyrvinium pamoate induces death of triple-negative breast cancer stem-like cells and reduces metastases through effects on lipid anabolism 43
Palliative- and non-palliative indications for glucocorticoids use in course of immune-checkpoint inhibition. Current evidence and future perspectives 43
The emerging role of cancer cell plasticity and cell-cycle quiescence in immune escape 43
Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study 42
Leptin receptor-mediated regulation of cholinergic neurotransmitter phenotype in cells of central nervous system origin 42
Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma 42
DNA sequence of a pseudogene for human C-reactive protein 42
Interleukin-6 an in vitro and in vivo autocrine growth factor for middle T antigen-transformed endothelial cells 42
Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance 41
CD8+ T CELL TOLERANCE CAN BE BROKEN BY AN ADENOVIRUS VACCINE WHILE CD4+ T CELL TOLERANCE IS BROKEN BY ADDITIONAL CO-ADMINISTRATION OF A TOLL-LIKE RECEPTOR LIGAND 41
Antigen-specificity and DTIC before peptide-vaccination differently shape immune-checkpoint expression pattern, anti-tumor functionality and TCR repertoire in melanoma patients 41
Intratumor RNA interference of cell cycle genes slows down tumor progression 41
Epigenetic Changes Induced by Green Tea Catechins are Associated with Prostate Cancer 41
MULTI-ANTIGEN CONSTRUCT AND USES THEREOF 41
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 41
The reciprocal interplay between miR-579-3p and MITF controls melanoma proliferation and resistance to target therapy 41
Electro gene-transfer results in a high level transduction of rat skeletal muscle and corrects anaemia of renal failure 41
ALDOC- and ENO2- driven glucose metabolism sustains 3D tumor spheroids growth regardless of nutrient environmental conditions: a multi-omics analysis 40
Deducing the functional characteristics of the human selenoprotein SELK from the structural properties of its intrinsically disordered C-terminal domain 40
Liver-Specific –Alpha 2 Interferon Gene Expression Results in Protection from Induced Hepatitis 40
Phenotype characterization of human melanoma cells resistant to dabrafenib 40
Definition of a complex binding site for gp130 in human interleukin-6 (IL-6) 40
Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli December 2nd-4th 2012" 40
The elapsed time during a virtual reality treatment for stressful procedures. A pool analysis on breast cancer patients during chemotherapy 40
B4GALT1 Is a New Candidate to Maintain the Stemness of Lung Cancer Stem Cells 40
Neoadjuvant Endocrine Therapy in Breast Cancer: Current Knowledge and Future Perspectives 40
T-cell agonists in cancer immunotherapy 40
Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver 40
Prospective Validation of the Italian Alliance Against Cancer Lung Panel in Patients With Advanced Non–Small-Cell Lung Cancer 40
Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth 39
The potential of BRAF-associated non-coding RNA as a therapeutic target in melanoma 39
ORTHOGONAL GENE SWITCHES 39
Human IL-6 receptor super-antagonists with high potency and wide spectrum on multiple myeloma cells 39
Totale 5.243
Salva come PNG Salva come JPEG
Categoria #
all - tutte 218.530
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 218.530
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021184 0 0 0 0 20 7 45 23 41 26 4 18
2021/20221.332 20 5 9 316 114 27 60 287 119 153 211 11
2022/20233.544 1.002 62 32 348 446 333 1 259 605 201 212 43
2023/20241.420 349 215 129 79 63 380 49 22 16 24 43 51
2024/20254.729 788 408 184 150 173 601 76 197 702 255 303 892
2025/20265.821 446 1.433 1.553 2.313 76 0 0 0 0 0 0 0
Totale 17.359